Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Research Article

Compliance of Private Primary Health Care Facilities Towards Requirements of Labelling of Dispensed Medicine in Sarawak

Author(s): Shing Chyi Loo*, Luqman Nulhakim Said, Logavinod Nakaswaram, Yik Hui Lee, Ee Ming Yii and Benodict Apok Anak Talin

Volume 17, Issue 3, 2022

Published on: 12 January, 2022

Page: [176 - 182] Pages: 7

DOI: 10.2174/1574886316666211006113948

Price: $65

Abstract

Background: Compliance towards the requirements of labelling of dispensed medicine (LDM) among private primary health care facilities ensures appropriate use of medicines.

Aims: This study aimed to examine the rate of compliance towards the requirements of LDM among retail pharmacies (RPs) and private medical clinics (PMCs).

Methods: A cross-sectional study was conducted from April 2019 to January 2020 across all inspected premises in Sarawak. Publics who attended RPs and PMCs and have medicines dispensed have their medicine labels examined for compliance with the requirements of LDM upon exiting the premises. Their verbal consents were obtained and the compliance score was recorded into self- -developed data collection forms. The compliance rate was the percentage of requirements on the examined medicine labels that fulfill the requirements under Regulation 12 of Poisons Regulations 1952.

Results: A total of 414 LDM were examined, with 135 from RPs and 279 from PMCs. The full compliance towards the requirements of LDM among RPs and PMCs were 23.7% and 41.6%, respectively. The median compliance score of PMCs (0.83) was significantly higher (P<0.001) than RPs (0.67). The requirements of LDM with the lowest compliance were name of medicine (53.1%), followed by name of patient (31.9%) and date of dispensing (25.6%).

Conclusion: The full compliance rate on the requirements of LDM among RPs and PMCs were low. More stringent enforcement and public education on their rights for fully compliant medicine labels could improve the compliance.

Keywords: Compliance, private primary health care facilities, labelling of dispensed medicine, dispensed medicine label, medicines, private medical clinics.

Graphical Abstract

[1]
Wolf MS, Davis TC, Curtis LM, et al. A patient-centered prescription drug label to promote appropriate medication use and adherence. J Gen Intern Med 2016; 31(12): 1482-9.
[http://dx.doi.org/10.1007/s11606-016-3816-x] [PMID: 27542666]
[2]
Anto B, Barlow D, Oborne A, Cape A, Vlassoff A, Whittlesea C. Dispensing-label errors in hospital: Types and potential causes. Int J Pharm Pract 2010; 18(2): 122-4.
[http://dx.doi.org/10.1211/ijpp/18.02.0008] [PMID: 20441122]
[3]
Neoh CF, Hassali MA, Shafie AA, Awaisu A, Tambyappa J. Compliance towards dispensed medication labelling standards: A cross-sectional study in the state of Penang, Malaysia. Curr Drug Saf 2009; 4(3): 199-203.
[http://dx.doi.org/10.2174/157488609789006921] [PMID: 19534650]
[4]
La Caze A. Safer dispensing labels for prescription medicines. Aust Prescr 2018; 41(2): 46-9.
[http://dx.doi.org/10.18773/austprescr.2018.009] [PMID: 29670311]
[5]
Malik M, Hussain A, Amin T, Hashmi A. Role of drug labeling in promoting rational dispensing: A literature review. 2016; 15(12): 74-8.
[6]
Boonstra E, Lindbaek M, Ngome E, Tshukudu K, Fugelli P. Labelling and patient knowledge of dispensed drugs as quality indicators in primary care in Botswana. Qual Saf Health Care 2003; 12(3): 168-75.
[http://dx.doi.org/10.1136/qhc.12.3.168] [PMID: 12792005]
[7]
Athuraliya N, Walkom EJ, Dharmaratne S, Robertson J. Assessing medication packaging and labelling appropriateness in Sri Lanka. J Pharm Policy Pract 2016; 9(1): 38.
[http://dx.doi.org/10.1186/s40545-016-0091-5] [PMID: 27933178]
[8]
Legal Research Board. Poison Regulations 1952.Malaysian Laws on Poisons and Sale of Drugs. International Law Book Services 2020; pp. 173-90.
[9]
Ting CY, Loo SC, Ting H, Ang WC, Hassan A, Abd A. Compliance of community pharmacists and private general medical practitioners with malaysian laws on poisons and sale of drugs. 2017; 51: 439-5.
[http://dx.doi.org/10.1177/2168479017699531]
[10]
Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Med Stat Arch Orofac Sci 2006; (1): 9-14. Available from:http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.504.2129&rep=rep1&type=pdf
[11]
Legal research board. Poison act 1952 (ACT366).Malaysian Laws on Poisons and Sale of Drugs. International Law Book Services 2020; pp. 1-172.
[12]
Loo SC. Assess the effectiveness of interventions on knowledge of nurses towards High Alert Medications (HAMs) in hospital Kanowit. Sarawak J Pharm 2016; 1: 23.
[13]
Wolf MS, Davis TC, Shrank W, et al. To err is human: Patient misinterpretations of prescription drug label instructions. 2007; 67: 293-300.
[http://dx.doi.org/10.1016/j.pec.2007.03.024]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy